Â鶹ÊÓƵ

That rarity – a hostile takeover bid – offers a chance to make a quick buck

Take two similar companies yet each gets good performance by very different means

We had almost forgotten that volatility is normal for financial markets

Glaxo should be a takeover target, but that doesn’t justify its presence in an income portfolio

Value does not respond well to attention. It has to be coaxed out

A first stab at finding new holdings for the Bearbull Income portfolio focuses on Aim stocks

The performance of the Bearbull income portfolio was a bit above average in 2017, even if it doesn’t feel like it

Two losers will rein in the Bearbull Income Fund’s performance in the second half of 2017

The ‘great disgruntlement’ will shape investment as well as politics for years to come

The ‘problem of knowledge’ – it’s the problem that many investors don’t like to acknowledge